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The original version of this article unfortunately contains an error in Table 2. The pneumococcal vaccination recommendations for Ireland are incorrectly shown in Table 2. These recommendations have been corrected in the table below. The authors wish to apologize for these errors.

**Table 2** National adult pneumococcal vaccination recommendations in Western Europe (Ireland)Pneumococcal vaccine recommendationCountry (Date)^a^VaccineAge basedAt-risk based, with definition of riskIreland\
(2013) \[94\]PCV13/PPV23No***High-risk group (18--64 years):*** Asplenia, hyposplenia (including splenectomy, sickle cell disease, hemoglobinopathies, and coeliac disease); cochlear implant (candidates, recipients); complement deficiency (particularly C1-C4); CSF leak (congenital, complicating skull fracture, neurosurgery); immunosuppressive conditions (e.g. some B- and T-cell disorders, HIV infection, leukaemia, lymphoma) and those receiving immunosuppressive therapies; intracranial shunt; post-haematopoietic stem-cell transplant; solid organ transplantIreland (2013) \[94\]PPV23≥65 years***Medium-risk group (18--64 years):*** chronic heart, lung, or liver disease; chronic renal disease or nephrotic syndrome; diabetes mellitus requiring insulin or oral hypoglycaemic drugs; individuals with occupational exposure to metal fumes (i.e. welders); smokers and alcoholics

^a^Date of implementation of recommendation

CSF, cerebrospinal fluid; CNS, central nervous system; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; IPD, invasive pneumococcal disease; PCV, pneumococcal conjugate vaccine; PPV, pneumococcal polysaccharide vaccine; SCID, severe combined immunodeficiency

The online version of the original article can be found at 10.1007/s10096-014-2208-6.
